42 CFR 423.2708
§ 423.2708 Conditions for coverage of drugs under Part D.
United States · 42 CFR — Public Health · Status: effective
Cite this
- Citation
- 42 CFR 423.2708, § 423.2708 Conditions for coverage of drugs under Part D, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/205140
- Permanent ID
ys:prov:205140@1- SHA-256
943b23f2271036b2b5aef9d846054aa6cccaf9186fcf722b5c603477c77e6cd0
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) General rule. Except as specified in paragraph (c) of this section, in order for coverage to be available under Part D for a Part D drug of a manufacturer that is an applicable drug or a selected drug during a price applicability period—
(1) The FDA-assigned labeler code of such applicable drug or selected drug must be covered by a Manufacturer Discount Program agreement (described at § 423.2752) that is in effect;
(2) The manufacturer must participate in the Manufacturer Discount Program in accordance with paragraph (b) of this section; and
(3) The manufacturer must have entered into and have in effect a Manufacturer Discount Program agreement in accordance with paragraph (b) of this section.
(b) Participation in the Manufacturer Discount Program. A manufacturer is considered to participate in the Manufacturer Discount Program and to have entered into and have in effect a Manufacturer Discount Program agreement for the purposes of paragraph (a) of this section if the manufacturer does either of the following:
(1) Executes and has in effect its own Manufacturer Discount Program agreement.
(2) Participates in the Manufacturer Discount Program by means of an arrangement whereby its labeler code(s) is covered by another manufacturer's Manufacturer Discount Program agreement that is in effect.
(c) Exception. Paragraph (a) of this section does not apply to an applicable drug that is not covered by a Manufacturer Discount Program agreement if CMS has made a determination that the availability of the drug is essential to the health of Part D enrollees. This exception to the general rule in paragraph (a) of this section does not apply to any applicable drug or selected drug of a manufacturer for any period described in section 5000D(c)(1) of the Internal Revenue Code of 1986 with respect to such manufacturer.
(d) Non-applicable drugs. Coverage under Part D is available for non-applicable drugs (as defined at § 423.100) of a manufacturer regardless of whether the manufacturer participates in the Manufacturer Discount Program or has a Manufacturer Discount Program agreement in effect.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.